负压封闭引流术联合银离子敷料治疗难愈性烧伤创面的临床效果

的 探究负压封闭引流术联合银离子敷料在难愈性烧伤创面治疗中的应用效果。方法 选择2021年8月-2023年2月京山市人民医院收治的80例难愈性烧伤患者为研究对象,以随机数字表法分为对照组和试验组,每组40例。对照组接受负压封闭引流术（VSD）治疗,试验组接受负压封闭引流术联合银离子敷料治疗,比较两组创面恢复情况、临床指标、疼痛程度、创面分泌物细菌检出率及并发症发生率。结果 试验组创面红期时间、创面愈合时间及敷料维持时间均优于对照组（P＜0.05）;试验组换药次数、住院时间及治疗总费用均优于对照组（P＜0.05）;试验组治疗后VAS评分低于对照组（P＜0.05）;两组治疗后创面分泌物细菌检出率均低于治疗前,且试验组低于对照组（P＜0.05）;试验组并发症发生率为2.50%,低于对照组的15.00%（P＜0.05）。结论 采用负压封闭引流术联合银离子敷料治疗难愈性烧伤创面的效果良好,可有效促进创面愈合,提高敷料使用率,减轻疼痛,同时可降低创面分泌物细菌检出率和并发症发生几率,有利于促进患者快速康复出院,减少治疗费用,减轻患者的经济负担。     

浸浴结合银离子敷料治疗大面积烧伤患者残余创面的疗效

目的 观察浸浴结合银离子敷料治疗大面积烧伤患者残余创面的疗效. 方法 2008年1月-2012年2月笔者单位收治90例大面积烧伤后期残余创面患者,按照随机数字表法分为对照组45例和试验组45例,对照组患者浸浴后创面外用磺胺嘧啶银纱布处理,试验组患者浸浴后以银离子敷料覆盖创面.用药后21 d,评定2组患者的治愈率.观察治疗过程中患者的不良反应.用药前及用药后7、14、21 d,分离与鉴定细菌,并计算创面细菌清除率.对数据进行x2检验和t检验.结果 用药后21 d,对照组与试验组患者的创面治愈率分别为62.22％(28/45)、86.67％(39/45),组间比较差异有统计学意义(x 2=7.067,P＜0.05).用药后2组患者均未见明显不良反应.用药前及用药后7、14 d,2组患者均检出金黄色葡萄球菌、表皮葡萄球菌、铜绿假单胞菌、大肠埃希菌等.试验组患者用药后7、14 d细菌清除率分别为50.0％、71.4％,明显高于对照组(x2值分别为8.067、5.896,P＜0.05或P＜0.01).用药后21 d,2组患者细菌清除率均为100.0％. 结论 浸浴疗法结合银离子敷料治疗烧伤后残余创面能有效控制创面感染,显著提高治愈率.     

负压封闭引流联合银离子敷料治疗难愈性创面的临床疗效

目的 探讨负压封闭引流（VSD）联合银离子敷料（SID）治疗难愈性创面（RW）的疗效。方法 回顾性分析60例难愈性创面（RW）病历资料,均于2018年1月至2021年6月温岭市第四人民医院与浙江省台州医院收治患者,根据不同的治疗方法分入治疗组与对照组均30例。治疗组采取SID+VSD治疗;对照组给予单纯VSD治疗。比较两组细菌培养（+）率、创面完全愈合时间与住院时间、疼痛视觉模拟评分法（VAS）评分、愈合后瘢痕温哥华瘢痕量表（VSS）评分、不良反应情况。结果 治疗后1、2周,治疗组细菌培养阳性率分别显著低于对照组（P<0.01）;治疗组RW患者的创面完全愈合时间与住院时间均分别显著低于对照组（P<0.01）;治疗后2周,治疗组VAS评分显著低于对照组（P<0.01）;治疗后1、2个月,治疗组RW患者VSS评分分别显著低于对照组（P<0.01）;对照组不良反应率30.00%,治疗组不良反应率为6.67%,治疗组显著低于对照组组（P<0.05）。结论 VSD联合SID治疗RW的抑菌效果好,可缩短创面愈合时间,减轻疼痛和瘢痕增生程度,以及降低不良反应发生。     

浸浴结合人工生物敷料和重组牛成纤维细胞生长因子2治疗烧伤后期残余创面的观察

目的观察浸浴结合人工生物敷料和重组牛成纤维细胞生长因子2（rb-FGF2）治疗烧伤后期残余创面的效果。方法将有烧伤后期残余创面的56例患者分为试验组（28例）和对照组（28例）。试验组患者浸浴后，将生物敷料覆盖于创面行半暴露疗法，用rb-FGF2喷湿敷料2次／d，每2～3天浸浴1次并更换敷料；对照组刨面消毒后仅以单层碘伏纱布覆盖行半暴露疗法。1个疗程（10d）结束后，比较两组患者的治愈率、有效率、创面细菌学情况及相关安全性指标。结果试验组和对照组患者的治愈率、有效率、细菌清除率分别为64．3％、89．3％、92．3％和32．1％、67．9％、72．0％，两组上述指标比较，差异均有统计学意义（P＜0．01）。两组患者未发生不良反应。结论浸浴结合应用新型人工生物敷料和rb-FGF2治疗烧伤后期残余创面安全、有效，可控制创面感染、提高治愈率。     

新鲜血浆盐水外敷治疗烧伤残余创面

笔者单位 1991～ 2 0 0 1年共收治烧伤残余创面患者 83例 ,其中男 5 5例、女 2 8例。烧伤面积 2 5 %～ 92 % ,残余创面1%～ 2 4 %〔(14 .3± 8 6 ) %〕TBSA ,残余创面时间为伤后 2～10个月〔(96 .0± 16 5 )d〕。创面细菌混合感染 5 9例 ,耐甲氧西林金黄色葡萄球菌 36例次 ,铜绿假单胞菌 2 5例次 ,阴沟肠杆菌 2 3例次 ,粪肠球菌 19例次 ,表皮葡萄球菌 15例次。将 83例患者分为两组 :新鲜血浆盐水外敷治疗组 (A组 ) 4 2例 ,采用同血型患者输血浆后的剩余部分 ,在无菌条件下加入适量等渗盐水混匀 ,使血浆浓度为 2 0 % ,加入到常用抗生素敷…     

速愈乐创面敷料在骨科难愈性创面愈合中的应用

目的:分析速愈乐创面敷料在促进骨科难愈性创面愈合中的应用效果。方法:选择2021年3月-2022年3月笔者医院骨科收治的慢性难愈性创面患者79例作为观察对象,按随机数字表法分为试验组(n=40例,给予速愈乐创面敷料治疗)和对照组(n=39例,给予常规凡士林纱布外敷治疗)。比较两组治愈时间、换药次数、医疗费用、创面面积缩小率和愈合率、疼痛情况以及两组治疗效果,采用创面愈合评分表(Pressure ulcer scale for healing,PUSH)比较两组愈合效果。结果:试验组治愈时间短于对照组、换药次数少于对照组、医疗费用低于对照组,差异均有统计学意义(P<0.05);试验组创面面积缩小率和相对愈合速率均高于对照组(P<0.05),治疗后两组疼痛视觉模拟评分(Visual analogue scale,VAS)均低于治疗前,且试验组VAS评分低于对照组(P<0.05);试验组创面治疗有效率为95.00%,高于对照组的79.49%(P<0.05);治疗后两组PUSH评分均低于治疗前,且试验组治疗后不同时间点PUSH评分均低于对照组,存在组间、时间和交互意义(...     

纳米银敷料联合重组人表皮生长因子凝胶治疗烧伤创面疗效观察

目的:观察纳米银敷料联合重组人表皮生长因子凝胶治疗深Ⅱ度烧伤患者的临床疗效.方法:选取2017年5月-2020年5月笔者医院收治的180例深Ⅱ度烧伤患者,随机分为联合组、凝胶组和敷料组,每组各60例.凝胶组给予重组人表皮生长因子凝胶治疗,敷料组给予纳米银敷料治疗,联合组给予重组人表皮生长因子凝胶联合纳米银敷料干预治疗....     

中药浸浴疗法联合脂质水胶体敷料及优质护理在中度烧伤后残余创面修复中的应用效果

目的 分析中药浸浴疗法联合脂质水胶体敷料及优质护理在中度烧伤后残余创面修复中的应用 效果。方法 选取2022年6月-2023年2月我院烧伤整形外科收治的50例中度烧伤后残余创面患者为研究对 象,随机分为对照组和观察组,各25例。对照组采用常规西医治疗配合常规护理,观察组采用中药浸浴 疗法联合脂质水胶体敷料法治疗,同时配合优质护理,比较两组临床指标、创面恢复情况、疼痛程度及 瘢痕情况。结果 观察组换药持续时间、创面愈合时间、住院时间均短于对照组（P＜0.05）;两组创面 感染发生率、创面愈合率比较,差异无统计学意义（P＞0.05）;两组治疗6 d后VAS评分均低于治疗前, 且观察组低于对照组（P＜0.05）;两组治疗后3个月VSS评分均低于治疗后1个月,且观察组低于对照组 （P＜0.05）。结论 中药浸浴疗法联合脂质水胶体敷料及优质护理在中度烧伤后残余创面修复中的应用效 果确切,可缩短换药时间,减少换药次数,加快创面愈合愈合速度,同时能够减轻疼痛,促进患者尽早康 复出院,并有效改善瘢痕情况     

烧伤患者难愈性创面多重耐药菌回顾性分析

目的分析烧伤外科病房难愈性创面多重耐药菌（MDRO）定植感染情况，为临床感染防控提供依据。 方法对2012年1月至2017年12月中国人民解放军海军第九〇五医院烧伤外科住院患者难愈性创面的细菌学资料进行调查，回顾性分析MDRO的分布、检出率及特殊耐药情况。 结果难愈性创面分离出270株MDRO，其中革兰阳性菌128株（47.41%），革兰阴性菌142株（52.59%）。居前5位的MDRO依次为金黄色葡萄球菌（125株）、铜绿假单胞菌（56株）、大肠埃希菌（30株）、肺炎克雷伯菌（19株）和鲍曼不动杆菌（18株）。MDRO平均检出率为77.14%，以上前5位MDRO检出率分别为88.65%、65.12%、90.91%、100.00%和90.00%。特殊耐药菌株中，耐甲氧西林金黄色葡萄球菌共118株，碳青霉烯类耐药的铜绿假单胞菌、鲍曼不动杆菌和肺炎克雷伯菌分别为42株、12株和5株。 结论烧伤外科病房难愈性创面MDRO分布广泛、检出率高，应采取有效的感染防控措施。     

酒精石蜡油用于烧伤残余创面疗效观察

目的探讨酒精石蜡油混悬液在烧伤残余创面治疗中的应用。方法共46例重度烧伤后期存在残余创面[1]患者,随机分成两组,每组23例。创面采用1次/2天换药方式处理;对照组换药时用聚维酮碘（浙江普洛康裕制药有限公司）及生理盐水清洗消毒,治疗组换药时用酒精和轻质液状石蜡油混悬液清洗创面代替上述清洗消毒措施;记录本治疗开始后7天、14天、21天及28天创面愈合率;用五点口述分级评分法[2]记录每次换药时疼痛值;分别记录7天、14天、21天及28天创面分泌物细菌学检查结果。结果治疗组14天后角化皮基本清除,对照组病程中角化皮均存在,治疗组7天、14天创面愈合率与对照组无明显差异,21天、28天创面愈合率明显优于对照组,创面分泌物细菌学检查阳性结果例数明显低于对照组,两组病例换药时疼痛值记录统计无明显差异。结论用酒精石蜡油混悬液清洗创面代替常规清洗消毒能加速角化皮清除,更有效清洁创面,促进引流,降低创面菌落数,从而明显促进残余创面愈合,治疗未明显增加疼痛不适。     

A comparative study to evaluate the effect of honey dressing and silver sulfadiazene dressing on wound healing in burn patients

To compare the effect of honey dressing and silver-sulfadiazene (SSD) dressing on wound healing in burn patients. Patients (n=78) of both sexes, with age group between 10 and 50 years and with first and second degree of burn of less than 50% of TBSA (Total body surface area) were included in the study, over a period of 2 years (2006-08). After stabilization, patients were randomly attributed into two groups: ‘honey group’ and ‘SSD group’. Time elapsed since burn was recorded. After washing with normal saline, undiluted pure honey was applied over the wounds of patients in the honey group (n=37) and SSD cream over the wounds of patients in SSD group (n=41), everyday. Wound was dressed with sterile gauze, cotton pads and bandaged. Status of the wound was assessed every third and seventh day and on the day of completion of study. Patients were followed up every fortnight till epithelialization. The bacteriological examination of the wound was done every seventh day. The mean age for case (honey group) and control (SSD group) was 34.5 years and 28.5 years, respectively. Wound swab culture was positive in 29 out of 36 patients who came within 8 hours of burn and in all patients who came after 24 hours. The average duration of healing in patients treated with honey and SSD dressing at any time of admission was 18.16 and 32.68 days, respectively. Wound of all those patients (100%) who reported within 1 hour became sterile with honey dressing in less than 7 days while none with SSD. All of the wounds became sterile in less than 21 days with honey, while tthis was so in only 36.5% with SSD treated wounds. The honey group included 33 patients reported within 24 hour of injury, and 26 out of them had complete outcome at 2 months of follow-up, while numbers for the SSD group were 32 and 12. Complete outcome for any admission point of time after 2 months was noted in 81% and 37% of patients in the honey group and the SSD group. Honey dressing improves wound healing, makes the wound sterile in lesser time, has a better outcome in terms of prevention of hypertrophic scarring and post-burn contractures, and decreases the need of debridement irrespective of time of admission, when compared to SSD dressing.     

Clinical efficacy of wet dressing combined with chitosan wound dressing in the treatment of deep second-degree burn wounds: A prospective,randomised, single-blind,positive control clinical trial

To evaluate the efficacy and safety of wet dressing combined with chitosan wound dressing for deep II degree burn wounds, and provide the basis for clinical application. From October 2019 to October 2021, 80 patients with second-degree deep burn treated in the Department of burn and plastic surgery of our hospital were selected as the research objects. Patients were randomly divided into two groups. The control group (40n) was treated with wet compress, and the study group (40n) was treated with wet compress combined with chitosan wound dressing. The wound healing time, wound healing percentage and pain score were used as the effectiveness indexes, and the incidence of adverse events and serious adverse events and the detection rate of bacterial culture of wound exudates were used as the safety indexes. The efficacy and safety of the two groups were compared. The wound healing time of the study group (19.53 ± 2.74 days) was shorter than that of the control group (24.78 ± 4.86 days), the difference was significant (t = 3.571, P = 0.015). The percentage of wound healing at the 14th after treatment in the study group was higher than that in the control group (65.00% versus 37.50%) (X² = 6.054, P = 0.014). There was no significant difference in pain scores between the two groups at each time point. The scar growth was observed 3 months after wound healing. The scar score of the study group (6.00 ± 0.98) was lower than that of the control group (8.77 ± 1.19) (t = 2.571, P = 0.031). The positive rate of wound secretion culture on the 7th and 14th day was statistically significant (X² = 4.528, P = 0.033; X² = 6.646, P = 0.010), and the study group was lower than the control group (29.03% versus 81.82%; 8.11% versus 42.86%). There was no significant difference in treatment cost between the study group and the control group (1258.7 ± 223.6 versus 1248.9 ± 182.3) (t = 1.571, P = 0.071). No adverse events or serious adverse events occurred in both groups. Chitosan wound dressing can significantly shorten the time of wound healing and reduce wound pain and wound infection in patients with deep second-degree burns. And it can effectively improve the situation of scar hyperplasia, which is worthy of clinical application.     

Clinical efficacy of wet dressing combined with chitosan wound dressing in the treatment of deep second‐degree burn wounds: A prospective,randomised, single‐blind,positive control clinical trial

To evaluate the efficacy and safety of wet dressing combined with chitosan wound dressing for deep II degree burn wounds, and provide the basis for clinical application. From October 2019 to October 2021, 80 patients with second‐degree deep burn treated in the Department of burn and plastic surgery of our hospital were selected as the research objects. Patients were randomly divided into two groups. The control group (40n) was treated with wet compress, and the study group (40n) was treated with wet compress combined with chitosan wound dressing. The wound healing time, wound healing percentage and pain score were used as the effectiveness indexes, and the incidence of adverse events and serious adverse events and the detection rate of bacterial culture of wound exudates were used as the safety indexes. The efficacy and safety of the two groups were compared. The wound healing time of the study group (19.53 ± 2.74 days) was shorter than that of the control group (24.78 ± 4.86 days), the difference was significant (t = 3.571, P = 0.015). The percentage of wound healing at the 14th after treatment in the study group was higher than that in the control group (65.00% versus 37.50%) (X² = 6.054, P = 0.014). There was no significant difference in pain scores between the two groups at each time point. The scar growth was observed 3 months after wound healing. The scar score of the study group (6.00 ± 0.98) was lower than that of the control group (8.77 ± 1.19) (t = 2.571, P = 0.031). The positive rate of wound secretion culture on the 7th and 14th day was statistically significant (X² = 4.528, P = 0.033; X² = 6.646, P = 0.010), and the study group was lower than the control group (29.03% versus 81.82%; 8.11% versus 42.86%). There was no significant difference in treatment cost between the study group and the control group (1258.7 ± 223.6 versus 1248.9 ± 182.3) (t = 1.571, P = 0.071). No adverse events or serious adverse events occurred in both groups. Chitosan wound dressing can significantly shorten the time of wound healing and reduce wound pain and wound infection in patients with deep second‐degree burns. And it can effectively improve the situation of scar hyperplasia, which is worthy of clinical application.     

CTGF mRNA在植皮残余创面中的表达及其意义

目的：探讨结缔组织生长因子（CTGF）在植皮术后残余创面中的表达情况及可能的意义。方法：应用免疫组化（IHC）和半定量逆转录聚合酶链反应（RT—PCR）技术检测创面组织中CTGF蛋白和mRNA的表达。结果：CTGF蛋白及mRNA在残余创面组织中高度表达，CTGF阳性颗粒面密度及mRNA指数分别为（0．512±0．054）和（0．91±0．23），与正常皮肤组织比较差异有统计学意义（P〈0．01）；残余创面修复后，CTGF的表达下降到正常皮肤的水平。结论：CTGF可能在残余创面愈合的过程中发挥重要的促进作用。     

Comparison of silver nylon wound dressing and silver sulfadiazine in partial burn wound therapy

The study aims to perform a comparative assessment of two types of burn wound treatment. To do the assessment, patients with partial thickness burn wounds with total body surface area <40% were simple randomised to treat with nanocrystalline silver nylon wound dressing or silver sulfadiazine cream. Efficacy of treatment, use of analgesics, number of wound dressing change, wound infection and final hospitalisation cost were evaluated. The study showed silver nylon wound dressing significantly reduced length of hospital stay, analgesic use, wound infection and inflammation compared with silver sulfadiazine.     

Application of polycaprolactone,chitosan, and collagen composite as a nanofibrous mat loaded with silver sulfadiazine and growth factors for wound dressing

Fabrication of nanofibrous biomaterials composed of natural and synthetic materials that incorporated with antibiotic and growth factors with controlled release manner is an attractive topic in wound healing. The purpose of this study was to prepare optimal composite of materials as biomimetic nanofibrous mats for application in wound healing. The mat was prepared of polycaprolactone (PCL) in the bottom, chitosan/poly ethylene oxide (Cs/PEO) in the middle, and PCL/collagen (PCL/Coll) in the top layer. A panel of standard characterization tests of nanofibrous mat was performed and its compatibilities in strength and integration were confirmed. Middle layer was loaded with epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), and silver sulfadiazine (SSD) was incorporated in the bottom layer as an anti‐infection factor. Then, on the dorsum of rats, a 400‐mm² wound was created and surrounded by a silicone ring to control the usual tissue contractions. Nanofibrous mats with or without growth factors were applied as wound dressings and at day 14, the healing process was evaluated. At day 14, the treated group by designed mat showed faster epithelialization and angiogenesis. Silicone ring in the test group was desirable in wound closure compared to the control group. Reformation of skin tissue was manifested in a shorter time. This composite nanofibrous mat could be introduced as a dynamic and effective candidate for wound dressing.     

外用富林蜜凝胶治疗烧伤残余创面的多中心临床试验

目的 评价富林蜜凝胶在烧伤患者残余创面中的应用价值. 方法 2011年11月一2012年5月,选择6家笔者单位的60例烧伤残余创面患者进行多中心、随机、自身对照临床试验.将每例患者的2个残余创面按照随机数字表法分为治疗组与对照组,治疗组使用富林蜜凝胶处理,对照组采用碘伏纱布处理.用药后7、14 d比较2组创面的愈合率,并统计完全愈合创面数量;以视觉模拟评分法(VAS)评价患者每次换药的疼痛主诉,统计0分、大于0分且小于或等于3分、大于3分且小于或等于6分、大于6分且小于或等于10分的平均创面数量;统计2组创面的细菌检出情况并观察治疗过程中患者的不良反应.对数据进行重复测量方差分析、t检验、x 2检验或非参数秩和检验.结果 用药后7d,治疗组与对照组创面愈合率分别为(67±24)％和(45±25)％;用药后14 d,治疗组与对照组创面愈合率分别为(92±16)％和(72±23)％,组间比较差异有统计学意义(F=32.388,P ＜0.01).用药后7d,治疗组和对照组分别有10、4个残余创面愈合,组间比较差异无统计学意义(x2 =0,P＞0.05);用药后14 d,治疗组和对照组累计分别有42、7个残余创面愈合,组间比较差异有统计学意义(x 2 =42.254,P＜0.01).治疗组37个创面换药时患者感到轻微疼痛,VAS评分为大于0分且小于或等于3分;对照组43个创面换药时患者感到明显疼痛,VAS评分为大于3分且小于或等于6分,组间各级疼痛评分的平均创面数量比较,差异有统计学意义(Z=-4.638,P＜0.01).2组创面换药过程中检出的细菌包括金黄色葡萄球菌、铜绿假单胞菌、肺炎克雷伯菌、大肠杆菌、鲍氏不动杆菌、表皮葡萄球菌,组间比较差异无统计学意义(x2=0.051,P＞0.05).患者在用药过程中无不良反应. 结论 富林蜜凝胶可以显著促进烧伤残余创面愈合,明显减轻患者的疼痛.     

两种银敷料对慢性伤口愈合及渗液酸碱度影响的比较

目的比较两种银敷料辅助治疗慢性感染伤口的效果及对伤口渗液酸碱度的影响,以指导银敷料在慢性伤口治疗中的合理使用。方法将糖尿病足溃疡、压疮、下肢静脉溃疡、创伤性溃疡、烧伤残余创面5类慢性伤口患者104例随机分为A、B两组,每组52例。两组患者均按照统一方法评估、清洗和清创后,A组使用银离子藻酸盐敷料、B组使用纳米银敷料,分别接受30d的伤口局部辅助治疗。观察比较两组伤口治疗前及治疗后不同时间段的伤口愈合评分及渗液pH值。结果随着治疗时间的延长,两组伤口愈合计分和渗液pH值均较治疗前下降,A组患者伤口愈合计分显著优于B组(P0.01);两组伤口渗液pH值比较,差异无统计学意义(P0.05)。结论两种银敷料辅助治疗慢性感染伤口均能促进伤口愈合,但银离子藻酸盐敷料的效果更优;两种银敷料均能降低伤口渗液pH值且作用相当。     

重组人酸性成纤维细胞生长因子与纳米银敷料联合治疗深Ⅱ度烧伤创面的临床观察

目的:探讨重组人酸性成纤维细胞生长因子(recombinant human acidic fibroblast growth factor~rh-aFGF)与纳米银敷料联合应用治疗深Ⅱ度烧伤创面的疗效。方法:深Ⅱ度烧伤创面患者98例,随机采用自身对照选择相同深度的两个创面分为应用重组人酸性成纤维细胞生长因子(rh-aFGF)与纳米银敷料联合应用治疗组(简称治疗组);应用重组人酸性成纤维细胞生长因子(rh-aFGF)与凡士林纱布治疗(简称对照组)。结果:与对照组比较,治疗组创面愈合时间明显缩短。差异有统计学意义(P<0.05),抑(杀)菌效果显著。结论:重组人酸性成纤维细胞生长因子(rh-aFGF)与纳米银敷料联合应用治疗深Ⅱ度烧伤创面能明显促进深Ⅱ度创面愈合,有效抑制或杀灭烧伤创面病原菌,明显缩短深Ⅱ度烧伤创面愈合时间。